Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.
about
Regulation of Bim in Health and DiseaseCoadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic BimHigh BIM mRNA levels are associated with longer survival in advanced gastric cancerβ-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulationCancer subclonal genetic architecture as a key to personalized medicine.Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer.ROS-mediated EB1 phosphorylation through Akt/GSK3β pathway: implication in cancer cell response to microtubule-targeting agents.Activation of AKT/ERK confers non-small cell lung cancer cells resistance to vinorelbineHeat shock response associated with hepatocarcinogenesis in a murine model of hereditary tyrosinemia type I.Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition.Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: an ex vivo experiment in human serous ovarian carcinoma.BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer.[Effect and Significance of BIM on Non-small Cell Lung Cancer].
P2860
Q26781203-0C4496EA-3F20-41C1-B786-2E618D0A2EEAQ27322913-3B264EE4-299C-47FE-8C8C-ABD2D1A31DA8Q33598008-C1C103D9-2712-48BC-9FE4-5071A48F18BDQ36959073-CFB22D90-CCF8-467A-B89C-CEE044CA4BDBQ37376285-9B706537-A23B-4956-AC3A-827D831BEE4AQ37448116-23067A50-538E-4884-A97F-8C436D3B0535Q38777929-EFA16D41-6CC0-43D9-B63A-C0AD314F1180Q38806879-AFCF8146-A6C2-4A33-ACD6-8C8024853ADFQ38984621-0A5B2085-7E3A-445B-B466-B9658F8BCCACQ39034224-55D4928F-FA17-4027-9328-C632F7BF928EQ41457848-A294AD56-B82C-479A-AA1C-0A15D41350D8Q41515117-A8AA02AA-32D4-412C-8CFC-25DBE9A49362Q42704678-F9990436-7E97-40DF-9B1F-3CEFA4FEF308Q50921709-F22DF062-2244-40FF-BA84-D2C2AFBB4BD6Q55484299-5C08B3DE-B9EB-46D9-BCE3-81514F2AC8F1
P2860
Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Bcl-2-enhanced efficacy of mic ...... ications for cancer treatment.
@ast
Bcl-2-enhanced efficacy of mic ...... ications for cancer treatment.
@en
type
label
Bcl-2-enhanced efficacy of mic ...... ications for cancer treatment.
@ast
Bcl-2-enhanced efficacy of mic ...... ications for cancer treatment.
@en
prefLabel
Bcl-2-enhanced efficacy of mic ...... ications for cancer treatment.
@ast
Bcl-2-enhanced efficacy of mic ...... ications for cancer treatment.
@en
P2093
P2860
P356
P1433
P1476
Bcl-2-enhanced efficacy of mic ...... ications for cancer treatment.
@en
P2093
Amandine Rovini
Amandine Savry
Christine Chacon
Diane Braguer
Isabelle Pobel
Manon Carre
Raphael Berges
Véronique Bourgarel-Rey
P2860
P356
10.1593/NEO.121074
P577
2013-01-01T00:00:00Z